ProShare Advisors LLC trimmed its position in Genpact Limited (NYSE:G – Free Report) by 37.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 239,208 shares of the business services provider’s stock after selling 144,158 shares during the quarter. ProShare Advisors LLC owned approximately 0.14% of Genpact worth $7,781,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in G. Fifth Third Bancorp lifted its stake in Genpact by 8.8% during the first quarter. Fifth Third Bancorp now owns 3,691 shares of the business services provider’s stock worth $137,000 after purchasing an additional 300 shares during the last quarter. Basecamp Wealth Advisors LLC increased its stake in Genpact by 54.7% during the first quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider’s stock valued at $39,000 after purchasing an additional 370 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Genpact by 2.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 17,309 shares of the business services provider’s stock worth $645,000 after buying an additional 410 shares during the last quarter. WPG Advisers LLC lifted its position in shares of Genpact by 74.6% in the 1st quarter. WPG Advisers LLC now owns 1,037 shares of the business services provider’s stock worth $39,000 after buying an additional 443 shares during the last quarter. Finally, Elevation Wealth Partners LLC lifted its position in shares of Genpact by 57.2% in the 3rd quarter. Elevation Wealth Partners LLC now owns 1,339 shares of the business services provider’s stock worth $44,000 after buying an additional 487 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, SVP Anil Nanduru sold 6,191 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the completion of the sale, the senior vice president owned 70,253 shares of the company’s stock, valued at $2,601,468.59. This represents a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.58% of the company’s stock.
Genpact Stock Performance
G opened at $40.78 on Thursday. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.44. The business’s 50 day moving average is $36.35 and its 200-day moving average is $35.56. The stock has a market cap of $6.82 billion, a PE ratio of 12.10, a price-to-earnings-growth ratio of 1.07 and a beta of 0.53. Genpact Limited has a twelve month low of $26.85 and a twelve month high of $48.64.
Genpact (NYSE:G – Get Free Report) last issued its quarterly earnings data on Tuesday, June 30th. The business services provider reported $1.00 earnings per share (EPS) for the quarter. Genpact had a return on equity of 23.34% and a net margin of 11.04%. The business had revenue of $1.34 billion during the quarter. On average, analysts predict that Genpact Limited will post 3.66 earnings per share for the current year.
Genpact Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 23rd. Shareholders of record on Thursday, December 10th will be given a dividend of $0.1875 per share. This represents a $0.75 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Thursday, December 10th. Genpact’s payout ratio is 22.26%.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on G shares. Needham & Company LLC lowered their price objective on shares of Genpact from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Friday, August 7th. TD Cowen lifted their target price on Genpact from $42.00 to $43.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Deutsche Bank Aktiengesellschaft set a $31.00 target price on Genpact in a report on Friday, July 10th. JPMorgan Chase & Co. increased their price target on Genpact from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Finally, Susquehanna raised their price target on Genpact from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, October 22nd. Two research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $39.67.
View Our Latest Stock Analysis on G
Genpact Company Profile
Genpact (NYSE: G) is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.
Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.
Featured Stories
- Five stocks we like better than Genpact
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
